Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple
Original Report
This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst.
Glass House Analysis
This development in the banking sector reflects broader tensions between regulatory pressure and financial industry practices. The banking system serves as the circulatory system of the economy; any disruption ripples through to small businesses, homebuyers, and everyday consumers who depend on credit access.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Trump ban on investor homebuying may come at cost of a bigger real estate deal
President Trump's plan to ban big investors from home ownership may not be the key to reviving the American Dream in affordable housing legislation.
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.
Not everyone can expect a bigger tax refund this year — what's actually driving your result
President Donald Trump has said this will be the "largest tax refund season of all time," as a result of his "big beautiful bill." Here's what the megabill means for taxpayers.
Event Wagers Face $143 Million Insider Problem as War Bets Boom
Early last Monday, a burst of concentrated trades set off a week in which Wall Street and Washington were abuzz about the possibility that insiders have been using early knowledge of President Donald...